- Home
- IOVA vs FLNC Comparison
IOVA vs FLNC Comparison
Compare IOVA & FLNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOVA
- FLNC
- Stock Information
- Founded
- IOVA 2007
- FLNC 2018
- Country
- IOVA United States
- FLNC United States
- Employees
- IOVA N/A
- FLNC N/A
- Industry
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- FLNC Industrial Machinery/Components
- Sector
- IOVA Health Care
- FLNC Miscellaneous
- Exchange
- IOVA Nasdaq
- FLNC Nasdaq
- Market Cap
- IOVA 975.1M
- FLNC 974.7M
- IPO Year
- IOVA N/A
- FLNC 2021
- Fundamental
- Price
- IOVA $2.18
- FLNC $14.00
- Analyst Decision
- IOVA Buy
- FLNC Hold
- Analyst Count
- IOVA 11
- FLNC 19
- Target Price
- IOVA $11.90
- FLNC $8.53
- AVG Volume (30 Days)
- IOVA 9.8M
- FLNC 7.8M
- Earning Date
- IOVA 11-06-2025
- FLNC 11-24-2025
- Dividend Yield
- IOVA N/A
- FLNC N/A
- EPS Growth
- IOVA N/A
- FLNC N/A
- EPS
- IOVA N/A
- FLNC N/A
- Revenue
- IOVA $241,525,000.00
- FLNC $2,449,087,000.00
- Revenue This Year
- IOVA $68.14
- FLNC N/A
- Revenue Next Year
- IOVA $56.64
- FLNC $21.84
- P/E Ratio
- IOVA N/A
- FLNC N/A
- Revenue Growth
- IOVA 636.99
- FLNC 14.26
- 52 Week Low
- IOVA $1.64
- FLNC $3.46
- 52 Week High
- IOVA $12.51
- FLNC $24.00
- Technical
- Relative Strength Index (RSI)
- IOVA 46.63
- FLNC 65.98
- Support Level
- IOVA $1.97
- FLNC $10.47
- Resistance Level
- IOVA $2.38
- FLNC $12.88
- Average True Range (ATR)
- IOVA 0.13
- FLNC 1.45
- MACD
- IOVA 0.02
- FLNC 0.43
- Stochastic Oscillator
- IOVA 48.78
- FLNC 73.48
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
About FLNC Fluence Energy Inc.
Fluence Energy Inc is enabling the global clean energy transition with market-leading energy storage products and services, and digital applications for renewables and storage. Geographically, it derives a majority of its revenue from the Americas.